Lucy Osborne Appointed Interim Director of IMS

We are pleased to announce that the appointment of Dr. Lucy Osborne as Interim Director of the Institute of Medical Science (IMS) has been approved by the Agenda Committee and confirmed by the Chairs of Academic Board and Governing Council and the President. Her one-year term began on July 1, 2025.

Dr. Osborne brings extensive academic and leadership experience having served as our Associate Director and previously as our Graduate Coordinator and Acting Director of the IMS. Her groundbreaking research on neurodevelopmental disorders has led to key discoveries and shaped global understanding in the field of medicine. Recognized with numerous accolades and multiple teaching awards, Dr. Osborne combines scientific excellence with visionary educational leadership.

We extend a warm welcome to Dr. Osborne as our new Interim Director, and look forward to her leadership and vision as we continue to advance excellence in medical research and education. We are confident that her guidance will inspire and support the continued growth and success of our Institute.

On behalf of the entire IMS community, we also extend our sincere gratitude to Dr. Mingyao Liu for his distinguished leadership of IMS since 2014.

Please join us in welcoming Dr. Osborne as she begins her new role.